{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:19:00Z","timestamp":1790839140355,"version":"4.1.0"},"reference-count":182,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"DOI":"10.3389\/fnins.2020.567129","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T05:18:20Z","timestamp":1603084700000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":51,"title":["Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes"],"prefix":"10.3389","volume":"14","author":[{"given":"Alessia","family":"Indrieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Pizzarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elvira","family":"De Leonibus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.2147\/OPTH.S15136","article-title":"Detection of retinal changes in Parkinson\u2019s disease with spectral-domain optical coherence tomography.","volume":"4","author":"Aaker","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/WNO.0b013e31828c4e1a","article-title":"Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease.","volume":"33","author":"Adam","year":"2013","journal-title":"J. Neuroophthalmol."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034891","article-title":"Optical coherence tomography in parkinsonian syndromes.","volume":"7","author":"Albrecht","year":"2012","journal-title":"PLoS One"},{"key":"B4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00417-017-3896-2","article-title":"Optical coherence tomography angiography: a review of current and future clinical applications.","volume":"256","author":"Ang","year":"2018","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.parkreldis.2011.03.004","article-title":"Retinal thickness in Parkinson\u2019s disease.","volume":"17","author":"Archibald","year":"","journal-title":"Parkinsonism Relat. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1002\/mds.23891","article-title":"Visual symptoms in Parkinson\u2019s disease and Parkinson\u2019s disease dementia.","volume":"26","author":"Archibald","year":"","journal-title":"Mov. Disord."},{"key":"B7","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1444-0938.2010.00504.x","article-title":"Visual signs and symptoms of progressive supranuclear palsy.","volume":"94","author":"Armstrong","year":"2011","journal-title":"Clin. Exp. Optom."},{"key":"B8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3233\/JPD-150686","article-title":"Oculo-visual dysfunction in Parkinson\u2019s disease.","volume":"5","author":"Armstrong","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"B9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1148\/radiol.2017161732","article-title":"Visual system involvement in patients with newly diagnosed Parkinson disease.","volume":"285","author":"Arrigo","year":"2017","journal-title":"Radiology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.kjms.2017.11.006","article-title":"Optical coherence tomography findings in Parkinson\u2019s disease.","volume":"34","author":"Aydin","year":"2018","journal-title":"Kaohsiung J. Med. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neulet.2014.04.027","article-title":"Phosphorylated alpha-synuclein-immunoreactive retinal neuronal elements in Parkinson\u2019s disease subjects.","volume":"571","author":"Beach","year":"2014","journal-title":"Neurosci. Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.neuron.2013.09.004","article-title":"The function of alpha-synuclein.","volume":"79","author":"Bendor","year":"2013","journal-title":"Neuron"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1002\/mds.25272","article-title":"Color discrimination deficits in Parkinson\u2019s disease are related to cognitive impairment and white-matter alterations.","volume":"27","author":"Bertrand","year":"2012","journal-title":"Mov. Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease.","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.neuint.2006.08.001","article-title":"A rat model of Parkinsonism shows depletion of dopamine in the retina.","volume":"50","author":"Biehlmaier","year":"2007","journal-title":"Neurochem. Int."},{"key":"B16","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The genetic architecture of Parkinson\u2019s disease.","volume":"19","author":"Blauwendraat","year":"2019","journal-title":"Lancet Neurol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson\u2019s disease.","volume":"2012","author":"Blesa","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1212\/wnl.38.2.336","article-title":"Visual contrast sensitivity.","volume":"38","author":"Bodis-Wollner","year":"1988","journal-title":"Neurology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2012.07.012","article-title":"Foveal vision is impaired in Parkinson\u2019s disease.","volume":"19","author":"Bodis-Wollner","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"B20","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1002\/ana.24182","article-title":"alpha-synuclein in the inner retina in Parkinson disease.","volume":"75","author":"Bodis-Wollner","year":"","journal-title":"Ann. Neurol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/mds.25741","article-title":"Venturing into the no-man\u2019s land of the retina in Parkinson\u2019s disease.","volume":"29","author":"Bodis-Wollner","year":"","journal-title":"Mov. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1093\/brain\/110.6.1675","article-title":"Visual dysfunction in Parkinson\u2019s disease. Loss in spatiotemporal contrast sensitivity.","volume":"110","author":"Bodis-Wollner","year":"1987","journal-title":"Brain"},{"key":"B23","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S0042-6989(98)00028-5","article-title":"The push-pull action of dopamine on spatial tuning of the monkey retina: the effects of dopaminergic deficiency and selective D1 and D2 receptor ligands on the pattern electroretinogram.","volume":"38","author":"Bodis-Wollner","year":"1998","journal-title":"Vision Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1111\/jnc.13731","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease.","volume":"139","author":"Bose","year":"2016","journal-title":"J. Neurochem."},{"key":"B25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease.","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson\u2019s disease-related pathology.","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.neubiorev.2007.09.004","article-title":"The possible role of retinal dopaminergic system in visual performance.","volume":"32","author":"Brandies","year":"2008","journal-title":"Neurosci. Biobehav. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/ana.410220313","article-title":"Effect of levodopa treatment on contrast sensitivity in Parkinson\u2019s disease.","volume":"22","author":"Bulens","year":"1987","journal-title":"Ann. Neurol."},{"key":"B29","first-page":"1","article-title":"[The electroretinogram and visual evoked potentials in patients with Parkinson\u2019s disease].","volume":"53","author":"Burguera","year":"1990","journal-title":"Arch. Neurobiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1212\/wnl.45.2.386","article-title":"Distorted color discrimination in \u2018de novo\u2019 parkinsonian patients.","volume":"45","author":"Buttner","year":"1995","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/bf02252659","article-title":"L-Dopa improves colour vision in Parkinson\u2019s disease.","volume":"7","author":"Buttner","year":"1994","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1002\/mds.23101","article-title":"Abnormal visual activation in Parkinson\u2019s disease patients.","volume":"25","author":"Cardoso","year":"2010","journal-title":"Mov. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.bbabio.2009.02.024","article-title":"Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders.","volume":"1787","author":"Carelli","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B34","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neuropsychologia.2008.09.003","article-title":"Motion integration deficits are independent of magnocellular impairment in Parkinson\u2019s disease.","volume":"47","author":"Castelo-Branco","year":"2009","journal-title":"Neuropsychologia"},{"key":"B35","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41593-020-0589-7","article-title":"Gut-seeded alpha-synuclein fibrils promote gut dysfunction and brain pathology specifically in aged mice.","volume":"23","author":"Challis","year":"2020","journal-title":"Nat. Neurosci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2013.03.018","article-title":"Mitochondrial diseases of the brain.","volume":"63","author":"Chaturvedi","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1523\/JNEUROSCI.0089-14.2015","article-title":"A53T human alpha-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.","volume":"35","author":"Chen","year":"2015","journal-title":"J. Neurosci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1073\/pnas.1218424110","article-title":"Large alpha-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking.","volume":"110","author":"Choi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B39","doi-asserted-by":"publisher","first-page":"10814","DOI":"10.1074\/jbc.M110.132514","article-title":"Mutant A53T alpha-synuclein induces neuronal death by increasing mitochondrial autophagy.","volume":"286","author":"Choubey","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B40","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00415-017-8588-7","article-title":"Non-CNS pathogenic origin of Parkinson\u2019s disease.","volume":"264","author":"Choudhry","year":"2017","journal-title":"J. Neurol."},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-016-0333-4","article-title":"Uncoupling neuronal death and dysfunction in Drosophila models of neurodegenerative disease.","volume":"4","author":"Chouhan","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"B42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.14802\/jmd.19046","article-title":"Modeling alpha-synuclein propagation with preformed fibril injections.","volume":"12","author":"Chung","year":"2019","journal-title":"J. Mov. Disord."},{"key":"B43","article-title":"Clinical electrophysiology","author":"Creel","year":"1995","journal-title":"Webvision: The Organization of the Retina and Visual System"},{"key":"B44","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1002\/mds.23215","article-title":"Retina thickness in Parkinson\u2019s disease and essential tremor.","volume":"25","author":"Cubo","year":"2010","journal-title":"Mov. Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/cne.20761","article-title":"Morphological impairments in retinal neurons of the scotopic visual pathway in a monkey model of Parkinson\u2019s disease.","volume":"493","author":"Cuenca","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"B46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic Parkinsonism secondary to intravenous injection of meperidine analogues.","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res."},{"key":"B47","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson\u2019s disease.","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol."},{"key":"B48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-vision-082114-035334","article-title":"Functional circuitry of the retina.","volume":"1","author":"Demb","year":"2015","journal-title":"Annu. Rev. Vis. Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.arr.2017.12.007","article-title":"The genetics of Parkinson disease.","volume":"42","author":"Deng","year":"2018","journal-title":"Ageing Res. Rev."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf3634","article-title":"alpha-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson\u2019s disease.","volume":"8","author":"Di Maio","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/mds.20308","article-title":"Repeated visual hallucinations in Parkinson\u2019s disease as disturbed external\/internal perceptions: focused review and a new integrative model.","volume":"20","author":"Diederich","year":"2005","journal-title":"Mov. Disord."},{"key":"B52","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/mds.22963","article-title":"Discriminative power of different nonmotor signs in early Parkinson\u2019s disease. A case-control study.","volume":"25","author":"Diederich","year":"2010","journal-title":"Mov. Disord."},{"key":"B53","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1001\/archneur.59.8.1249","article-title":"Progressive worsening of spatial and chromatic processing deficits in Parkinson disease.","volume":"59","author":"Diederich","year":"2002","journal-title":"Arch. Neurol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.15252\/embj.201490101","article-title":"DUBs counteract parkin for efficient mitophagy.","volume":"33","author":"Dikic","year":"2014","journal-title":"EMBO J."},{"key":"B55","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1126\/science.804181","article-title":"Synaptic organization of the amine-containing interplexiform cells of the goldfish and Cebus monkey retinas.","volume":"188","author":"Dowling","year":"1975","journal-title":"Science"},{"key":"B56","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/13554794.2012.713497","article-title":"Damage to the dorsomedial thalamic nucleus, central lateral intralaminar thalamic nucleus, and midline thalamic nuclei on the right-side impair executive function and attention under conditions of high demand but not low demand.","volume":"20","author":"Edelstyn","year":"2014","journal-title":"Neurocase"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.014","article-title":"Ocular and visual disorders in Parkinson\u2019s disease: common but frequently overlooked.","volume":"40","author":"Ekker","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"B58","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1002\/ana.24294","article-title":"Mutual exacerbation of peroxisome proliferator-activated receptor gamma coactivator 1alpha deregulation and alpha-synuclein oligomerization.","volume":"77","author":"Eschbach","year":"2015","journal-title":"Ann. Neurol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.nbd.2011.06.009","article-title":"Rotenone induces degeneration of photoreceptors and impairs the dopaminergic system in the rat retina.","volume":"44","author":"Esteve-Rudd","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"B60","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease: molecular mechanisms and pathophysiological consequences.","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J."},{"key":"B61","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.1523\/JNEUROSCI.18-17-06776.1998","article-title":"Spontaneous activity of solitary dopaminergic cells of the retina.","volume":"18","author":"Feigenspan","year":"1998","journal-title":"J. Neurosci."},{"key":"B62","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors.","volume":"123","author":"Fenelon","year":"2000","journal-title":"Brain"},{"key":"B63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0024-3205(88)90315-3","article-title":"Systemic 1-methyl,4-phenyl,1-2-3-6-tetrahydropyridine (MPTP) administration decreases retinal dopamine content in primates.","volume":"43","author":"Ghilardi","year":"1988","journal-title":"Life Sci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/ana.410250407","article-title":"The effect of intraocular 6-hydroxydopamine on retinal processing of primates.","volume":"25","author":"Ghilardi","year":"1989","journal-title":"Ann. Neurol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/mds.26966","article-title":"Mitochondrial DNA and primary mitochondrial dysfunction in Parkinson\u2019s disease.","volume":"32","author":"Giannoccaro","year":"2017","journal-title":"Mov. Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1093\/brain\/awx351","article-title":"Motor learning and metaplasticity in striatal neurons: relevance for Parkinson\u2019s disease.","volume":"141","author":"Giordano","year":"2018","journal-title":"Brain"},{"key":"B67","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0013-4694(87)90032-0","article-title":"Alteration of visual evoked potentials and electroretinograms in Parkinson\u2019s disease.","volume":"66","author":"Gottlob","year":"1987","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1080\/13854046.2013.827744","article-title":"Reliability of three Benton judgment of line orientation short forms in idiopathic Parkinson\u2019s disease.","volume":"27","author":"Gullett","year":"2013","journal-title":"Clin. Neuropsychol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1002\/mds.27454","article-title":"Oculo-visual abnormalities in Parkinson\u2019s disease: possible value as biomarkers.","volume":"33","author":"Guo","year":"2018","journal-title":"Mov. Disord."},{"key":"B70","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1523\/JNEUROSCI.19-18-07812.1999","article-title":"Composition of the GABA(A) receptors of retinal dopaminergic neurons.","volume":"19","author":"Gustincich","year":"1999","journal-title":"J. Neurosci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0896-6273(00)80313-x","article-title":"Control of dopamine release in the retina: a transgenic approach to neural networks.","volume":"18","author":"Gustincich","year":"1997","journal-title":"Neuron"},{"key":"B72","first-page":"2473","article-title":"Decreased dopamine in the retinas of patients with Parkinson\u2019s disease.","volume":"31","author":"Harnois","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B73","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1093\/brain\/118.3.771","article-title":"Predominant affection of the blue cone pathway in Parkinson\u2019s disease.","volume":"118","author":"Haug","year":"1995","journal-title":"Brain"},{"key":"B74","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/mds.870090510","article-title":"Visual thresholds to low-contrast pattern displacement, color contrast, and luminance contrast stimuli in Parkinson\u2019s disease.","volume":"9","author":"Haug","year":"1994","journal-title":"Mov. Disord."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3201308","article-title":"Meta-analysis of visual evoked potential and Parkinson\u2019s disease.","volume":"2018","author":"He","year":"2018","journal-title":"Parkinsons Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1152\/jn.00681.2017","article-title":"Abnormal visual gain control and excitotoxicity in early-onset Parkinson\u2019s disease Drosophila models.","volume":"119","author":"Himmelberg","year":"2018","journal-title":"J. Neurophysiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/hmg\/ddt061","article-title":"Dopaminergic expression of the Parkinsonian gene LRRK2-G2019S leads to non-autonomous visual neurodegeneration, accelerated by increased neural demands for energy.","volume":"22","author":"Hindle","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"B78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/bpa.12070","article-title":"Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer\u2019s and Parkinson\u2019s disease patients.","volume":"24","author":"Ho","year":"2014","journal-title":"Brain Pathol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/jnnp.70.6.734","article-title":"Prospective study of hallucinations and delusions in Parkinson\u2019s disease.","volume":"70","author":"Holroyd","year":"2001","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B80","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archneur.1993.00540070041012","article-title":"Levodopa improves spatial contrast sensitivity in Parkinson\u2019s disease.","volume":"50","author":"Hutton","year":"1993","journal-title":"Arch. Neurol."},{"key":"B81","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1016\/0042-6989(94)90248-8","article-title":"Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson\u2019s disease and a follow up study.","volume":"34","author":"Ikeda","year":"1994","journal-title":"Vision Res."},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21062092","article-title":"The pervasive role of the miR-181 family in development, neurodegeneration, and cancer.","volume":"21","author":"Indrieri","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708734","article-title":"miR-181a\/b downregulation exerts a protective action on mitochondrial disease models.","volume":"11","author":"Indrieri","year":"2019","journal-title":"EMBO Mol. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1016\/j.visres.2004.06.009","article-title":"Retinal nerve fiber layer thinning in Parkinson disease.","volume":"44","author":"Inzelberg","year":"2004","journal-title":"Vision Res."},{"key":"B85","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1474-4422(13)70056-5","article-title":"Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study.","volume":"12","author":"Iranzo","year":"2013","journal-title":"Lancet Neurol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0896-6273(95)90302-x","article-title":"The precursor protein of non-A beta component of Alzheimer\u2019s disease amyloid is a presynaptic protein of the central nervous system.","volume":"14","author":"Iwai","year":"1995","journal-title":"Neuron"},{"key":"B87","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1523\/JNEUROSCI.0711-12.2012","article-title":"Retinal dopamine mediates multiple dimensions of light-adapted vision.","volume":"32","author":"Jackson","year":"2012","journal-title":"J. Neurosci."},{"key":"B88","doi-asserted-by":"publisher","first-page":"E4016","DOI":"10.1073\/pnas.1309143110","article-title":"Deficits in dopaminergic transmission precede neuron loss and dysfunction in a new Parkinson model.","volume":"110","author":"Janezic","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B89","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B90","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0166-2236(00)01789-6","article-title":"Parkinson\u2019s disease, pesticides and mitochondrial dysfunction.","volume":"24","author":"Jenner","year":"2001","journal-title":"Trends Neurosci."},{"key":"B91","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mds.870070308","article-title":"Impairment of high-contrast visual acuity in Parkinson\u2019s disease.","volume":"7","author":"Jones","year":"1992","journal-title":"Mov. Disord."},{"key":"B92","doi-asserted-by":"crossref","first-page":"6365","DOI":"10.1523\/JNEUROSCI.20-17-06365.2000","article-title":"Subcellular localization of wild-type and Parkinson\u2019s disease-associated mutant alpha -synuclein in human and transgenic mouse brain.","volume":"20","author":"Kahle","year":"2000","journal-title":"J. Neurosci."},{"key":"B93","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease.","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1038\/emboj.2010.223","article-title":"Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1.","volume":"29","author":"Kamp","year":"2010","journal-title":"EMBO J."},{"key":"B95","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/WNO.0b013e3182701745","article-title":"Retinal nerve fiber layer thickness in Parkinson disease.","volume":"33","author":"Kirbas","year":"2013","journal-title":"J. Neuroophthalmol."},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/srep44373","article-title":"Nix restores mitophagy and mitochondrial function to protect against PINK1\/Parkin-related Parkinson\u2019s disease.","volume":"7","author":"Koentjoro","year":"2017","journal-title":"Sci. Rep."},{"key":"B97","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1001\/archneur.1982.00510170026007","article-title":"Visual system abnormalities in patients with Parkinson\u2019s disease.","volume":"39","author":"Kupersmith","year":"1982","journal-title":"Arch. Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1468-1331.2012.03701.x","article-title":"Loss of temporal retinal nerve fibers in Parkinson disease: a mitochondrial pattern?","volume":"20","author":"La Morgia","year":"2013","journal-title":"Eur. J. Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"B100","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3233\/JPD-130306","article-title":"Optical coherence tomography in Parkinson\u2019s disease: is the retina a biomarker?","volume":"4","author":"Lee","year":"","journal-title":"J. Parkinsons Dis."},{"key":"B101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mds.25543","article-title":"Retinal nerve fiber layer thickness and visual hallucinations in Parkinson\u2019s Disease.","volume":"29","author":"Lee","year":"","journal-title":"Mov. Disord."},{"key":"B102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/NEN.0b013e31820376cc","article-title":"Protein aggregation in the aging retina.","volume":"70","author":"Leger","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"B103","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3233\/JPD-140470","article-title":"Abnormal visual contrast acuity in Parkinson\u2019s disease.","volume":"5","author":"Lin","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.703","article-title":"Evoked potential changes in patients with Parkinson\u2019s disease.","volume":"7","author":"Liu","year":"2017","journal-title":"Brain Behav."},{"key":"B105","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1073\/pnas.1200575109","article-title":"Impaired neurotransmission caused by overexpression of alpha-synuclein in nigral dopamine neurons.","volume":"109","author":"Lundblad","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B106","doi-asserted-by":"publisher","first-page":"681","DOI":"10.3233\/JPD-150685","article-title":"The concept of prodromal Parkinson\u2019s disease.","volume":"5","author":"Mahlknecht","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"B107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.09.013","article-title":"Accelerated accumulation of retinal alpha-synuclein (pSer129) and tau, neuroinflammation, and autophagic dysregulation in a seeded mouse model of Parkinson\u2019s disease.","volume":"121","author":"Mammadova","year":"2019","journal-title":"Neurobiol. Dis."},{"key":"B108","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.mcn.2012.08.004","article-title":"The optic nerve: a \u201cmito-window\u201d on mitochondrial neurodegeneration.","volume":"55","author":"Maresca","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"B109","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","article-title":"Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers.","volume":"77","author":"Marras","year":"2011","journal-title":"Neurology"},{"key":"B110","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-66497-6","article-title":"\u03b1-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells.","volume":"10","author":"Marrocco","year":"2020","journal-title":"Sci. Rep."},{"key":"B111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1523\/JNEUROSCI.4308-05.2006","article-title":"Parkinson\u2019s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death.","volume":"26","author":"Martin","year":"2006","journal-title":"J. Neurosci."},{"key":"B112","first-page":"949","article-title":"Alpha synuclein gene expression profile in the retina of vertebrates.","volume":"13","author":"Martinez-Navarrete","year":"2007","journal-title":"Mol. Vis."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","article-title":"Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.","volume":"287","author":"Masliah","year":"2000","journal-title":"Science"},{"key":"B114","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.parkreldis.2018.06.016","article-title":"Retinal changes in Parkinson\u2019s disease and glaucoma.","volume":"56","author":"Matlach","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B115","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1177\/0891988705284739","article-title":"Impaired visual acuity as a risk factor for visual hallucinations in Parkinson\u2019s disease.","volume":"19","author":"Matsui","year":"2006","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1600-0420.2007.01054.x","article-title":"Quantification and characterization of GABA-ergic amacrine cells in the retina of GAD67-GFP knock-in mice.","volume":"86","author":"May","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.preteyeres.2013.12.001","article-title":"Circadian organization of the mammalian retina: from gene regulation to physiology and diseases.","volume":"39","author":"McMahon","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"B118","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1007\/s11064-012-0706-4","article-title":"Contralateral retinal dopamine decrease and melatonin increase in progression of hemiparkinsonium rat.","volume":"37","author":"Meng","year":"2012","journal-title":"Neurochem. Res."},{"key":"B119","doi-asserted-by":"publisher","first-page":"S134","DOI":"10.1016\/j.parkreldis.2015.09.015","article-title":"A combination of retinal morphology and visual electrophysiology testing increases diagnostic yield in Parkinson\u2019s disease.","volume":"22","author":"Miri","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B120","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1076\/jcen.23.5.592.1248","article-title":"Visuospatial deficits in Parkinson\u2019s disease assessed by judgment of line orientation test: error analyses and practice effects.","volume":"23","author":"Montse","year":"2001","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3233\/JAD-121975","article-title":"Retinal nerve fiber layer thinning in dementia associated with Parkinson\u2019s disease, dementia with Lewy bodies, and Alzheimer\u2019s disease.","volume":"34","author":"Moreno-Ramos","year":"2013","journal-title":"J. Alzheimers Dis."},{"key":"B122","doi-asserted-by":"publisher","first-page":"24","DOI":"10.5301\/ejo.2010.1318","article-title":"Morphologic changes and functional retinal impairment in patients with Parkinson disease without visual loss.","volume":"21","author":"Moschos","year":"2011","journal-title":"Eur. J. Ophthalmol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1034\/j.1600-0404.2002.1o154.x","article-title":"Progress of visual dysfunction in Parkinson\u2019s disease.","volume":"105","author":"Muller","year":"2002","journal-title":"Acta Neurol. Scand."},{"key":"B124","doi-asserted-by":"publisher","first-page":"20710","DOI":"10.1074\/jbc.M110.213538","article-title":"Direct membrane association drives mitochondrial fission by the Parkinson disease-associated protein alpha-synuclein.","volume":"286","author":"Nakamura","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B125","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuron.2009.12.023","article-title":"Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis.","volume":"65","author":"Nemani","year":"2010","journal-title":"Neuron"},{"key":"B126","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/BF02307822","article-title":"Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson\u2019s disease.","volume":"10","author":"Nguyen-Legros","year":"1988","journal-title":"Surg. Radiol. Anat."},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-016-0346-z","article-title":"The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson\u2019s disease: evidence for a neuroprotective effect of rosiglitazone in the eye and brain.","volume":"4","author":"Normando","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"B128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10633-015-9503-0","article-title":"Bioelectrical function and structural assessment of the retina in patients with early stages of Parkinson\u2019s disease (PD).","volume":"131","author":"Nowacka","year":"2015","journal-title":"Doc. Ophthalmol."},{"key":"B129","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.neuron.2017.11.036","article-title":"alpha-synuclein induces mitochondrial dysfunction through spectrin and the actin cytoskeleton.","volume":"97","author":"Ordonez","year":"2018","journal-title":"Neuron"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","article-title":"Phosphorylated alpha-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity.","volume":"33","author":"Ortuno-Lizaran","year":"2018","journal-title":"Mov. Disord."},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25897","article-title":"Dopaminergic retinal cell loss and visual dysfunction in Parkinson\u2019s disease.","author":"Ortuno-Lizaran","year":"2020","journal-title":"Ann. Neurol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JPD-160779","article-title":"Implication of alpha-synuclein phosphorylation at S129 in synucleinopathies: what have we learned in the last decade?","volume":"6","author":"Oueslati","year":"2016","journal-title":"J. Parkinsons Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0022-510x(99)00204-x","article-title":"Decreased color discrimination and contrast sensitivity in Parkinson\u2019s disease.","volume":"172","author":"Pieri","year":"2000","journal-title":"J. Neurol. Sci."},{"key":"B134","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3233\/JPD-140359","article-title":"Color vision impairment in Parkinson\u2019s disease.","volume":"4","author":"Piro","year":"2014","journal-title":"J. Parkinsons Dis."},{"key":"B135","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-009658","article-title":"Visual dysfunction and its correlation with retinal changes in patients with Parkinson\u2019s disease: an observational cross-sectional study.","volume":"6","author":"Polo","year":"2016","journal-title":"BMJ Open"},{"key":"B136","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1080\/13554791003730600","article-title":"Visual spatial cognition in neurodegenerative disease.","volume":"16","author":"Possin","year":"2010","journal-title":"Neurocase"},{"key":"B137","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","article-title":"Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease.","volume":"27","author":"Postuma","year":"2012","journal-title":"Mov. Disord."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease.","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"B139","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1002\/ana.22282","article-title":"Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder.","volume":"69","author":"Postuma","year":"2011","journal-title":"Ann. Neurol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1212\/01.wnl.0000203648.80727.5b","article-title":"Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.","volume":"66","author":"Postuma","year":"2006","journal-title":"Neurology"},{"key":"B141","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/wnl.42.4.887","article-title":"Abnormalities in color vision and contrast sensitivity in Parkinson\u2019s disease.","volume":"42","author":"Price","year":"1992","journal-title":"Neurology"},{"key":"B142","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0896-6273(01)00274-4","article-title":"Extrasynaptic release of dopamine in a retinal neuron: activity dependence and transmitter modulation.","volume":"30","author":"Puopolo","year":"2001","journal-title":"Neuron"},{"key":"B143","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-017-0780-8","article-title":"New genes causing hereditary Parkinson\u2019s disease or Parkinsonism.","volume":"17","author":"Puschmann","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B144","doi-asserted-by":"crossref","first-page":"7585","DOI":"10.1016\/S0021-9258(19)57434-8","article-title":"Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.","volume":"261","author":"Ramsay","year":"1986","journal-title":"J. Biol. Chem."},{"key":"B145","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/bjo.68.12.885","article-title":"Low-contrast letter charts in early diabetic retinopathy, ocular hypertension, glaucoma, and Parkinson\u2019s disease.","volume":"68","author":"Regan","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"B146","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.parkreldis.2016.10.006","article-title":"Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease.","volume":"34","author":"Ridder","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"B147","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1586\/14737167.2015.1103184","article-title":"Estimating the direct and indirect costs associated with Parkinson\u2019s disease.","volume":"15","author":"Rodriguez-Blazquez","year":"2015","journal-title":"Expert Rev. Pharmacoecon. Outcomes Res."},{"key":"B148","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jphs.2019.03.006","article-title":"Dopaminergic modulation of retinal processing from starlight to sunlight.","volume":"140","author":"Roy","year":"2019","journal-title":"J. Pharmacol. Sci."},{"key":"B149","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1097\/01.wnp.0000216127.53517.4d","article-title":"Visual-evoked potentials to onset of chromatic red-green and blue-yellow gratings in Parkinson\u2019s disease never treated with L-dopa.","volume":"23","author":"Sartucci","year":"2006","journal-title":"J. Clin. Neurophysiol."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/8503859","article-title":"Optical coherence tomography as a biomarker for diagnosis, progression, and prognosis of neurodegenerative diseases.","volume":"2016","author":"Satue","year":"2016","journal-title":"J. Ophthalmol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1002\/cne.903550306","article-title":"Distribution and spatial geometry of dopamine interplexiform cells in the retina. II. External arborizations in the adult rat and monkey.","volume":"355","author":"Savy","year":"1995","journal-title":"J. Comp. Neurol."},{"key":"B152","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson\u2019s disease.","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1002\/mds.25974","article-title":"Retinal pathology detected by optical coherence tomography in an animal model of Parkinson\u2019s disease.","volume":"29","author":"Schneider","year":"2014","journal-title":"Mov. Disord."},{"key":"B154","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0165-6147(94)90323-9","article-title":"Dopamine receptor pharmacology.","volume":"15","author":"Seeman","year":"1994","journal-title":"Trends Pharmacol. Sci."},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/728457","article-title":"Interocular asymmetry of foveal thickness in Parkinson disease.","volume":"2012","author":"Shrier","year":"2012","journal-title":"J. Ophthalmol."},{"key":"B156","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/mds.24954","article-title":"Premotor Parkinson\u2019s disease: concepts and definitions.","volume":"27","author":"Siderowf","year":"2012","journal-title":"Mov. Disord."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1093\/brain\/awh581","article-title":"Independent patterns of damage within magno-, parvo- and koniocellular pathways in Parkinson\u2019s disease.","volume":"128","author":"Silva","year":"2005","journal-title":"Brain"},{"key":"B158","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies.","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"key":"B159","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00702-012-0909-5","article-title":"Remodeling of the fovea in Parkinson disease.","volume":"120","author":"Spund","year":"2013","journal-title":"J. Neural Transm."},{"key":"B160","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1016\/0042-6989(95)00037-z","article-title":"Increasing doses of l-sulpiride reveal dose- and spatial frequency-dependent effects of D2 selective blockade in the human electroretinogram.","volume":"35","author":"Stanzione","year":"1995","journal-title":"Vision Res."},{"key":"B161","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10072-014-1930-2","article-title":"Visual dysfunction in patients with Parkinson\u2019s disease and essential tremor.","volume":"36","author":"Stenc Bradvica","year":"2015","journal-title":"Neurol. Sci."},{"key":"B162","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/0042-6989(94)90316-6","article-title":"Spatial frequency tuning of the monkey pattern ERG depends on D2 receptor-linked action of dopamine.","volume":"34","author":"Tagliati","year":"1994","journal-title":"Vision Res."},{"key":"B163","first-page":"767","article-title":"[Effects of MPTP on the mouse retina].","volume":"96","author":"Takatsuna","year":"1992","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1136\/jnnp.50.9.1243","article-title":"Visual evoked potentials and pattern electroretinograms in Parkinson\u2019s disease and control subjects.","volume":"50","author":"Tartaglione","year":"1987","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B165","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0006-8993(90)91056-m","article-title":"MPTP produces reversible disappearance of tyrosine hydroxylase-containing retinal amacrine cells.","volume":"527","author":"Tatton","year":"1990","journal-title":"Brain Res."},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-12-54","article-title":"Perimetric and retinal nerve fiber layer findings in patients with Parkinson\u2019s disease.","volume":"12","author":"Tsironi","year":"2012","journal-title":"BMC Ophthalmol."},{"key":"B167","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s00415-018-9051-0","article-title":"Early ophthalmologic features of Parkinson\u2019s disease: a review of preceding clinical and diagnostic markers.","volume":"266","author":"Turcano","year":"2019","journal-title":"J. Neurol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1212\/01.wnl.0000191565.11065.11","article-title":"Visual dysfunction in Parkinson disease without dementia.","volume":"65","author":"Uc","year":"2005","journal-title":"Neurology"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2019.101729","article-title":"A multi-faceted genotoxic network of alpha-synuclein in the nucleus and mitochondria of dopaminergic neurons in Parkinson\u2019s disease: emerging concepts and challenges.","volume":"185","author":"Vasquez","year":"2020","journal-title":"Prog. Neurobiol."},{"key":"B170","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1111\/j.1460-9568.1996.tb01192.x","article-title":"Immunohistochemical localization of dopamine D1 receptors in rat retina.","volume":"8","author":"Veruki","year":"1996","journal-title":"Eur. J. Neurosci."},{"key":"B171","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s004150170051","article-title":"Colour discrimination impairment is not a reliable early marker of Parkinson\u2019s disease.","volume":"248","author":"Vesela","year":"2001","journal-title":"J. Neurol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00401-018-01956-z","article-title":"Retinal alpha-synuclein deposits in Parkinson\u2019s disease patients and animal models.","volume":"137","author":"Veys","year":"2019","journal-title":"Acta Neuropathol."},{"key":"B173","doi-asserted-by":"publisher","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson\u2019s disease.","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"key":"B174","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1167\/iovs.08-2913","article-title":"OPA1 deficiency associated with increased autophagy in retinal ganglion cells in a murine model of dominant optic atrophy.","volume":"50","author":"White","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"B175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s10863-009-9253-3","article-title":"The PINK1\/Parkin pathway: a mitochondrial quality control system?","volume":"41","author":"Whitworth","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"B176","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.brainres.2006.05.103","article-title":"Self-paced saccades and saccades to oddball targets in Parkinson\u2019s disease.","volume":"1106","author":"Winograd-Gurvich","year":"2006","journal-title":"Brain Res."},{"key":"B177","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/b:doop.0000019487.88486.0a","article-title":"Dopamine and retinal function.","volume":"108","author":"Witkovsky","year":"2004","journal-title":"Doc. Ophthalmol."},{"key":"B178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","article-title":"alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies.","volume":"23","author":"Wong","year":"2017","journal-title":"Nat. Med."},{"key":"B179","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1177\/112067210701700520","article-title":"The effect of levodopa and dopamine agonists on optic nerve head in Parkinson disease.","volume":"17","author":"Yavas","year":"2007","journal-title":"Eur. J. Ophthalmol."},{"key":"B180","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.preteyeres.2010.11.002","article-title":"Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.","volume":"30","author":"Yu-Wai-Man","year":"2011","journal-title":"Prog. Retin. Eye Res."},{"key":"B181","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00401-016-1625-2","article-title":"A neurodegenerative perspective on mitochondrial optic neuropathies.","volume":"132","author":"Yu-Wai-Man","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1alpha, a potential therapeutic target for early intervention in Parkinson\u2019s disease.","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2020.567129\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T06:38:18Z","timestamp":1617950298000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2020.567129\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":182,"alternative-id":["10.3389\/fnins.2020.567129"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2020.567129","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"article-number":"567129"}}